Literature DB >> 11465603

Propofol increases myofilament Ca2+ sensitivity and intracellular pH via activation of Na+-H+ exchange in rat ventricular myocytes.

N Kanaya1, P A Murray, D S Damron.   

Abstract

BACKGROUND: The objectives were to determine the extent and mechanism of action by which propofol increases myofilament Ca2+ sensitivity and intracellular pH (pHi) in ventricular myocytes.
METHODS: Freshly isolated adult rat ventricular myocytes were used for the study. Cardiac myofibrils were extracted for assessment of myofibrillar actomyosin adenosine triphosphatase (ATPase) activity. Myocyte shortening (video edge detection) and pHi (2',7'-bis-(2-carboxyethyl)-5(6')-carboxyfluorescein, 500/440 ratio) were monitored simultaneously in individual cells field-stimulated (0.3 Hz) and superfused with HEPES-buffered solution (pH 7.4, 30 degrees C).
RESULTS: Propofol (100 microM) reduced the Ca2+ concentration required for activation of myofibrillar actomyosin ATPase from pCa 5.7 +/- 0.01 to 6.6 +/- 0.01. Increasing pHi (7.05 +/- 0.03 to 7.39 +/- 0.04) with NH4Cl increased myocyte shortening by 35 +/- 12%. Washout of NH4Cl decreased pHi to 6.82 +/- 0.03 and decreased myocyte shortening to 52 +/- 10% of control. Propofol caused a dose-dependent increase in pHi but reduced myocyte shortening. The propofol-induced increase in pHi was attenuated, whereas the decrease in myocyte shortening was enhanced after pretreatment with ethylisopropyl amiloride, a Na+-H+ exchange inhibitor, or bisindolylmaleimide I, a protein kinase C inhibitor. Propofol also attenuated the NH4Cl-induced intracellular acidosis, increased the rate of recovery from acidosis, and attenuated the associated decrease in myocyte shortening. Propofol caused a leftward shift in the extracellular Ca2+-shortening relation, and this effect was attenuated by ethylisopropyl amiloride.
CONCLUSIONS: These results suggest that propofol increases the sensitivity of myofibrillar actomyosin ATPase to Ca2+ (ie., increases myofilament Ca2+ sensitivity), at least in part by increasing pHi via protein kinase C-dependent activation of Na+-H+ exchange.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465603     DOI: 10.1097/00000542-200106000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Propofol increases the Ca2+ sensitivity of BKCa in the cerebral arterial smooth muscle cells of mice.

Authors:  Xue-ru Liu; Xiao-qiu Tan; Yan Yang; Xiao-rong Zeng; Xian-ling Tang
Journal:  Acta Pharmacol Sin       Date:  2011-11-21       Impact factor: 6.150

2.  Molecular mechanism of anesthetic-induced depression of myocardial contraction.

Authors:  Tao Meng; Weiming Bu; Xianfeng Ren; Xinzhong Chen; Jingui Yu; Roderic G Eckenhoff; Wei Dong Gao
Journal:  FASEB J       Date:  2016-05-11       Impact factor: 5.191

3.  Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.

Authors:  Neil A Roberts; Robert S Haworth; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  Influence of CO2 pneumoperitoneum on intracellular pH and signal transduction in cancer cells.

Authors:  Li-Ping Cao; Guo-Ping Ding; Ri-Sheng Que; Shu Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

5.  Propofol activates and allosterically modulates recombinant protein kinase C epsilon.

Authors:  Peter J Wickley; Ryo Yuge; Brad A Martin; Jacob S Meyer; Derek S Damron
Journal:  Anesthesiology       Date:  2009-07       Impact factor: 7.892

6.  In vivo and ex vivo effects of propofol on myocardial performance in rats with obstructive jaundice.

Authors:  Hong-Mei Ren; Li-Qun Yang; Zhi-Qiang Liu; Cai-Yang Chen; Chi-Wai Cheung; Kun-Ming Tao; Jian-Gang Song; Wu-Rong Chen; Wei-Feng Yu
Journal:  BMC Gastroenterol       Date:  2011-12-28       Impact factor: 3.067

7.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.

Authors:  Rafat A Siddiqui; Mustapha Zerouga; Min Wu; Alicia Castillo; Kevin Harvey; Gary P Zaloga; William Stillwell
Journal:  Breast Cancer Res       Date:  2005-06-07       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.